Back

The ORION Program - Rationale and emerging evidence

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: The ORION Program - What to look for in ORION-11 Trial Design ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor David Kallend

The Medicines Company, Zurich (Switzerland)

5 More presentations in this session

Presentation thumbnail
Welcome and introductions.
Doctor B. Berkowitz (New York, US)
Slides Video
Presentation thumbnail
Atherosclerotic cardiovascular disease management has made significant progress but may have stalled recently.
Doctor C. Gibson (Boston, US)
Video
Presentation thumbnail
LDL-C and outcomes: Implementing 21st century cardiovascular trials
Professor L. Bowman (Oxford, GB)
Slides Video
Presentation thumbnail
Another PCSK-9 therapy?
Professor R. Wright (Rochester, US)
Slides Video
Presentation thumbnail
Approaches to critically assess the evidence. A checklist for ORION-11
Doctor C. Gibson (Boston, US)
Slides Video

Access the full session

Session thumbnail
The ORION Program - What to look for in ORION-11

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Real-world evaluation of an algorithmic machine-learning-guided testing approach in stable chest pain: a multinational, multicohort study
thumbnail
Congress Session
How to implement a successful telemedicine program in heart failure
thumbnail
Congress Presentation
AI-based drug design and AI-based clinical trials - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources